B1935
Butorphan S（+）-扁桃酸酯
≥98% (HPLC), solid
别名:
(−)-3-Hydroxy-N-cyclobutylmethylmorphinan S(+)-mandelate, MCL-101 Mandelate
InChI
1S/C21H29NO.C8H8O3/c23-17-8-7-16-12-20-18-6-1-2-9-21(18,19(16)13-17)10-11-22(20)14-15-4-3-5-15;9-7(8(10)11)6-4-2-1-3-5-6/h7-8,13,15,18,20,23H,1-6,9-12,14H2;1-5,7,9H,(H,10,11)/t18?,20-,21-;7-/m10/s1
InChI key
CBWUCCIELNNDND-QADVRDRQSA-N
SMILES string
O[C@H](C(O)=O)c1ccccc1.Oc2ccc3C[C@@H]4C5CCCC[C@]5(CCN4CC6CCC6)c3c2
assay
≥98% (HPLC)
form
solid
color
light yellow
solubility
DMSO: ~5 mg/mL
originator
Bristol-Myers Squibb
Biochem/physiol Actions
κ/μ opioid receptor agonist.
Features and Benefits
This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
J L Neumeyer et al.
Journal of medicinal chemistry, 43(1), 114-122 (2000-01-14)
This report concerns the synthesis and preliminary pharmacological evaluation of a novel series of kappa agonists related to the morphinan (-)-cyclorphan (3a) and the benzomorphan (-)-cyclazocine (2) as potential agents for the pharmacotherapy of cocaine abuse. Recent evidence suggests that
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持